Description: EuMederis Pharmaceuticals, Inc. designs novel, best-in-class peptide pharmaceuticals with improved bioavailability and efficacy. These clinical development candidates make use of our broadly-based, proprietary technology for peptide modification.
inc. (4122) diabetes (2543) pain (2387) obesity (416) osteoporosis (164) encinitas (163) peptide pharmaceuticals eumederis pharmaceuticals 270 north el camino real #108f
EuMederis Pharmaceuticals Sugar Land , TX 77479 United States ph: 858.967.4235 jnestor @eumederi s .com
EuMederis Pharmaceuticals, Inc. is focused on the design of novel, Best-in-Class peptide pharmaceuticals with improved bioavailability and efficacy in patients. These preclinical development candidates make use of our broadly-based, proprietary technology platform ( EuPort ) for the improvement of peptide drug action.
Initial products are directed at indications in pain, in control of osteoporosis, and in reversal of the inflammatory components of the metabolic syndrome.